Skip to main content

Table 3 Review of radiotherapy studies on orbital lymphoma.

From: Radiation therapy in primary orbital lymphoma: a single institution retrospective analysis

Series N° of patients Stage Histology Dose (Gy) Local
control
Survival at
5 years
Jereb et al.[3] 19 I, II and IV Low and intermediate 20-37.5 100% NA
Smitt et al.[9] 25 I-II Low, intermediate and high 28-40.2 89% 93%
Chao et al.[10] 20 I Low and intermediate 20-43.2 100% 90%
Bolek et al[11] 20 I-II Low, intermediate and high 15-53.3 95% Low 89%, interm and high 33%
Stafford et al[13] 48 I-II Low, intermediate and high 15-53.8 98% 88%
Liao et al.[32] 25 I Low and intermediate 30-40 100% NA
Bhatia et al.[15] 47 I Low, intermediate and high 20-51 100% 74%
Martinet et al.[18] 90 I-II Low, intermediate and high 4.0-50.4 97% 78%
Fung et al. [6] 98 I and III-IV MALT, Follicular DLBCL 16.2-46 98% Stage I,94%
III-IV, 49%
Zhou et al. [20] 46 I-IV Low, intermediate and high 30.6 98% 88%
Aviles et al.[33] 98 IE MALT 34-40 98% 96%
Bischof et al. [21] 42 I-IV Low, intermediate and high 20-46 80-100% Stage I, 91%
II, 80%
III-IV, 47%
Nam H et al.[34] 66 I MALT 20-45 97% NA
Son SH [35] 46 IE MALT 21.6-45 98% 100%
  1. DLBCL: diffuse large B-cell lymphoma, MALT: mucosa associated lymphoid tissue, NA: not assessed